This page shows information from a previous legislative session and is presented for archive purposes only.

SB505 - TO MANDATE THE COPRESCRIPTION OF AN OPIOID ANTAGONIST UNDER CERTAIN CONDITIONS; AND TO AMEND THE NALOXONE ACCESS ACT.


Bill Number:
SB505 PDF
SB505
Act Number:
Act 651 PDF
651
Status:
Senate -- Notification that SB505 is now Act 651
Originating Chamber:
Senate
Lead Sponsor:
Other Primary Sponsor:
Introduction Date:
3/9/2021 12:58:35 PM
Act Date:
4/12/2021

Upcoming Events

No upcoming events for this bill.


Bill Status History

Chamber
Date
Action
Vote
Senate
4/13/2021 10:44:45 PM
Notification that SB505 is now Act 651
Senate
4/8/2021 10:56:34 AM
DELIVERED TO GOVERNOR.
Senate
4/8/2021 10:56:30 AM
Reported correctly enrolled and ordered delivered to the Governor.
Senate
4/7/2021 6:10:01 PM
ORDERED ENROLLED
Senate
4/7/2021 6:09:53 PM
Returned from the House as passed.
House
4/7/2021 2:30:40 PM
Returned To the Senate as passed.
House
4/7/2021 2:30:34 PM
Read the third time and passed and ordered transmitted to the Senate.
House
4/6/2021 6:06:20 PM
Returned by the Committee Do Pass
House
3/18/2021 5:27:43 PM
Read the first time, rules suspended, read the second time and referred to the Committee on PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE- HOUSE
House
3/18/2021 4:34:21 PM
RECEIVED FROM THE SENATE
Senate
3/18/2021 2:32:46 PM
Ordered immediately transmitted to the House.
Senate
3/18/2021 2:32:35 PM
Read the third time and passed.
Senate
3/17/2021 5:49:28 PM
Returned by the Committee, with the recommendation that it Do Pass
Senate
3/9/2021 1:31:20 PM
Read first time, rules suspended, read second time, referred to PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE - SENATE
Senate
3/9/2021 12:58:41 PM
Filed